Corporate Governance
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
Corporate Governance
The members and charters for select committees of Enzon’s Board of Directors.
Board of Directors
= add file to Briefcase
To report complaints about Enzon’s accounting, internal accounting controls or auditing matters please call 866-276-2949 at any time of the day or night. You may also submit your complaint by e-mailing enzn@openboard.info or writing to:
Enzon Pharmaceuticals, Inc.Attn: Chief Compliance Officer
685 Route 202/206
Bridgewater, NJ 08807
You may communicate with Enzon’s Board of Directors by writing to:
Enzon Pharmaceuticals, Inc.
Attn: Chief Compliance Officer
685 Route 202/206
Bridgewater, NJ 08807
| (ENZN) NASDAQ | |
| Last Trade | 10.580 |
| Change(%) |
0.17
|
| Volume | 208,700 |
| Sep 2, 2010 4:00 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
-
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.
-
08-03-2010
Enzon Second Quarter Earnings Call
-
05-10-2010
First Quarter Earnings Call
-
02-17-2010
Fourth Quarter Earnings Call
-
11-03-2009
Third Quarter Earnings Call
-
Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
-
08-03-2010
Enzon Reports Second Quarter 2010 Results
Company continues to progress as an innovative oncology development company
-
07-28-2010
Enzon to Release Second Quarter 2010 Earnings on Tuesday, August 3, 2010; Conference Call and Webcast to Follow
-
05-10-2010
Enzon Reports 1st Quarter 2010 Results
--Company is transformed to be exclusively focused on its pipeline--
-
05-07-2010
Enzon Sets Date of 2010 Annual Meeting